# OnCo record nct07620574 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07620574/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07620574", "NCT07620574" ;
  schema:name "Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study"@en ;
  schema:description "A phase 3 trial of cabozantinib, zanzalintinib, atezolizumab, nivolumab and other drugs in colorectal cancer, run by Exelixis, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07620574/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07620574> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest", "colorectal-deep-dive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/rectal-cancer/>, <https://onco.cc/cancers/colon-cancer/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/cabozantinib/>, <https://onco.cc/drugs/zanzalintinib/>, <https://onco.cc/drugs/atezolizumab/>, <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/abiraterone/>, <https://onco.cc/drugs/prednisone/>, <https://onco.cc/drugs/enzalutamide/> ;
  onco:companies <https://onco.cc/companies/exelixis/>, <https://onco.cc/companies/bms/> .